Global Antihypertensive Agents Market Growth (Status and Outlook) 2022-2028
The global market for Antihypertensive Agents is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Antihypertensive Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Antihypertensive Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Antihypertensive Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Antihypertensive Agents market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Antihypertensive Agents players cover Baxter International, Pfizer, Sandoz, Teva Pharmaceuticals and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Antihypertensive Agents market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Antihypertensive Agents market, with both quantitative and qualitative data, to help readers understand how the Antihypertensive Agents market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Antihypertensive Agents market and forecasts the market size by Type (Thiazide Diuretics, Calcium Channel Blockers (CCB) and ACE Inhibitors), by Application (Children and Adult.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Thiazide Diuretics
Calcium Channel Blockers (CCB)
ACE Inhibitors
Angiotensin II Receptor Antagonists (ARBs)
Segmentation by application
Children
Adult
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Baxter International
Pfizer
Sandoz
Teva Pharmaceuticals
Bayer
Johnson & Johnson
Sun Pharmaceutical Industries
Merck
AstraZeneca
Daiichi Sankyo
Takeda
Actelion
Viatris
United Therapeutics
Lupin Limited
Hikma Pharmaceuticals
Aurobindo Pharma
Camber Pharmaceutical
Major Pharmaceuticals
Glenmark Pharmaceuticals
Zydus Pharmaceuticals
Amneal Pharmaceuticals
Endo International
Unichem Laboratories
Huahai Pharmaceutical
Shijiazhuang Pharma Group
Shanghai Shyndec Pharmaceutical
Chapter Introduction
Chapter 1: Scope of Antihypertensive Agents, Research Methodology, etc.
Chapter 2: Executive Summary, global Antihypertensive Agents market size and CAGR, Antihypertensive Agents market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Antihypertensive Agents revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Antihypertensive Agents revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Antihypertensive Agents market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Baxter International, Pfizer, Sandoz, Teva Pharmaceuticals, Bayer, Johnson & Johnson, Sun Pharmaceutical Industries, Merck and AstraZeneca, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antihypertensive Agents Market Size 2017-2028
2.1.2 Antihypertensive Agents Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Antihypertensive Agents Segment by Type
2.2.1 Thiazide Diuretics
2.2.2 Calcium Channel Blockers (CCB)
2.2.3 ACE Inhibitors
2.2.4 Angiotensin II Receptor Antagonists (ARBs)
2.3 Antihypertensive Agents Market Size by Type
2.3.1 Antihypertensive Agents Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Antihypertensive Agents Market Size Market Share by Type (2017-2022)
2.4 Antihypertensive Agents Segment by Application
2.4.1 Children
2.4.2 Adult
2.5 Antihypertensive Agents Market Size by Application
2.5.1 Antihypertensive Agents Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Antihypertensive Agents Market Size Market Share by Application (2017-2022)
3 Antihypertensive Agents Market Size by Player
3.1 Antihypertensive Agents Market Size Market Share by Players
3.1.1 Global Antihypertensive Agents Revenue by Players (2020-2022)
3.1.2 Global Antihypertensive Agents Revenue Market Share by Players (2020-2022)
3.2 Global Antihypertensive Agents Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Antihypertensive Agents by Regions
4.1 Antihypertensive Agents Market Size by Regions (2017-2022)
4.2 Americas Antihypertensive Agents Market Size Growth (2017-2022)
4.3 APAC Antihypertensive Agents Market Size Growth (2017-2022)
4.4 Europe Antihypertensive Agents Market Size Growth (2017-2022)
4.5 Middle East & Africa Antihypertensive Agents Market Size Growth (2017-2022)
5 Americas
5.1 Americas Antihypertensive Agents Market Size by Country (2017-2022)
5.2 Americas Antihypertensive Agents Market Size by Type (2017-2022)
5.3 Americas Antihypertensive Agents Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antihypertensive Agents Market Size by Region (2017-2022)
6.2 APAC Antihypertensive Agents Market Size by Type (2017-2022)
6.3 APAC Antihypertensive Agents Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Antihypertensive Agents by Country (2017-2022)
7.2 Europe Antihypertensive Agents Market Size by Type (2017-2022)
7.3 Europe Antihypertensive Agents Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antihypertensive Agents by Region (2017-2022)
8.2 Middle East & Africa Antihypertensive Agents Market Size by Type (2017-2022)
8.3 Middle East & Africa Antihypertensive Agents Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Antihypertensive Agents Market Forecast
10.1 Global Antihypertensive Agents Forecast by Regions (2023-2028)
10.1.1 Global Antihypertensive Agents Forecast by Regions (2023-2028)
10.1.2 Americas Antihypertensive Agents Forecast
10.1.3 APAC Antihypertensive Agents Forecast
10.1.4 Europe Antihypertensive Agents Forecast
10.1.5 Middle East & Africa Antihypertensive Agents Forecast
10.2 Americas Antihypertensive Agents Forecast by Country (2023-2028)
10.2.1 United States Antihypertensive Agents Market Forecast
10.2.2 Canada Antihypertensive Agents Market Forecast
10.2.3 Mexico Antihypertensive Agents Market Forecast
10.2.4 Brazil Antihypertensive Agents Market Forecast
10.3 APAC Antihypertensive Agents Forecast by Region (2023-2028)
10.3.1 China Antihypertensive Agents Market Forecast
10.3.2 Japan Antihypertensive Agents Market Forecast
10.3.3 Korea Antihypertensive Agents Market Forecast
10.3.4 Southeast Asia Antihypertensive Agents Market Forecast
10.3.5 India Antihypertensive Agents Market Forecast
10.3.6 Australia Antihypertensive Agents Market Forecast
10.4 Europe Antihypertensive Agents Forecast by Country (2023-2028)
10.4.1 Germany Antihypertensive Agents Market Forecast
10.4.2 France Antihypertensive Agents Market Forecast
10.4.3 UK Antihypertensive Agents Market Forecast
10.4.4 Italy Antihypertensive Agents Market Forecast
10.4.5 Russia Antihypertensive Agents Market Forecast
10.5 Middle East & Africa Antihypertensive Agents Forecast by Region (2023-2028)
10.5.1 Egypt Antihypertensive Agents Market Forecast
10.5.2 South Africa Antihypertensive Agents Market Forecast
10.5.3 Israel Antihypertensive Agents Market Forecast
10.5.4 Turkey Antihypertensive Agents Market Forecast
10.5.5 GCC Countries Antihypertensive Agents Market Forecast
10.6 Global Antihypertensive Agents Forecast by Type (2023-2028)
10.7 Global Antihypertensive Agents Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Baxter International
11.1.1 Baxter International Company Information
11.1.2 Baxter International Antihypertensive Agents Product Offered
11.1.3 Baxter International Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Baxter International Main Business Overview
11.1.5 Baxter International Latest Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Antihypertensive Agents Product Offered
11.2.3 Pfizer Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pfizer Main Business Overview
11.2.5 Pfizer Latest Developments
11.3 Sandoz
11.3.1 Sandoz Company Information
11.3.2 Sandoz Antihypertensive Agents Product Offered
11.3.3 Sandoz Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sandoz Main Business Overview
11.3.5 Sandoz Latest Developments
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Information
11.4.2 Teva Pharmaceuticals Antihypertensive Agents Product Offered
11.4.3 Teva Pharmaceuticals Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Teva Pharmaceuticals Main Business Overview
11.4.5 Teva Pharmaceuticals Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Antihypertensive Agents Product Offered
11.5.3 Bayer Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Antihypertensive Agents Product Offered
11.6.3 Johnson & Johnson Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Information
11.7.2 Sun Pharmaceutical Industries Antihypertensive Agents Product Offered
11.7.3 Sun Pharmaceutical Industries Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sun Pharmaceutical Industries Main Business Overview
11.7.5 Sun Pharmaceutical Industries Latest Developments
11.8 Merck
11.8.1 Merck Company Information
11.8.2 Merck Antihypertensive Agents Product Offered
11.8.3 Merck Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Merck Main Business Overview
11.8.5 Merck Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Antihypertensive Agents Product Offered
11.9.3 AstraZeneca Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Daiichi Sankyo
11.10.1 Daiichi Sankyo Company Information
11.10.2 Daiichi Sankyo Antihypertensive Agents Product Offered
11.10.3 Daiichi Sankyo Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Daiichi Sankyo Main Business Overview
11.10.5 Daiichi Sankyo Latest Developments
11.11 Takeda
11.11.1 Takeda Company Information
11.11.2 Takeda Antihypertensive Agents Product Offered
11.11.3 Takeda Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Takeda Main Business Overview
11.11.5 Takeda Latest Developments
11.12 Actelion
11.12.1 Actelion Company Information
11.12.2 Actelion Antihypertensive Agents Product Offered
11.12.3 Actelion Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Actelion Main Business Overview
11.12.5 Actelion Latest Developments
11.13 Viatris
11.13.1 Viatris Company Information
11.13.2 Viatris Antihypertensive Agents Product Offered
11.13.3 Viatris Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Viatris Main Business Overview
11.13.5 Viatris Latest Developments
11.14 United Therapeutics
11.14.1 United Therapeutics Company Information
11.14.2 United Therapeutics Antihypertensive Agents Product Offered
11.14.3 United Therapeutics Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 United Therapeutics Main Business Overview
11.14.5 United Therapeutics Latest Developments
11.15 Lupin Limited
11.15.1 Lupin Limited Company Information
11.15.2 Lupin Limited Antihypertensive Agents Product Offered
11.15.3 Lupin Limited Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Lupin Limited Main Business Overview
11.15.5 Lupin Limited Latest Developments
11.16 Hikma Pharmaceuticals
11.16.1 Hikma Pharmaceuticals Company Information
11.16.2 Hikma Pharmaceuticals Antihypertensive Agents Product Offered
11.16.3 Hikma Pharmaceuticals Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Hikma Pharmaceuticals Main Business Overview
11.16.5 Hikma Pharmaceuticals Latest Developments
11.17 Aurobindo Pharma
11.17.1 Aurobindo Pharma Company Information
11.17.2 Aurobindo Pharma Antihypertensive Agents Product Offered
11.17.3 Aurobindo Pharma Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Aurobindo Pharma Main Business Overview
11.17.5 Aurobindo Pharma Latest Developments
11.18 Camber Pharmaceutical
11.18.1 Camber Pharmaceutical Company Information
11.18.2 Camber Pharmaceutical Antihypertensive Agents Product Offered
11.18.3 Camber Pharmaceutical Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Camber Pharmaceutical Main Business Overview
11.18.5 Camber Pharmaceutical Latest Developments
11.19 Major Pharmaceuticals
11.19.1 Major Pharmaceuticals Company Information
11.19.2 Major Pharmaceuticals Antihypertensive Agents Product Offered
11.19.3 Major Pharmaceuticals Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Major Pharmaceuticals Main Business Overview
11.19.5 Major Pharmaceuticals Latest Developments
11.20 Glenmark Pharmaceuticals
11.20.1 Glenmark Pharmaceuticals Company Information
11.20.2 Glenmark Pharmaceuticals Antihypertensive Agents Product Offered
11.20.3 Glenmark Pharmaceuticals Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Glenmark Pharmaceuticals Main Business Overview
11.20.5 Glenmark Pharmaceuticals Latest Developments
11.21 Zydus Pharmaceuticals
11.21.1 Zydus Pharmaceuticals Company Information
11.21.2 Zydus Pharmaceuticals Antihypertensive Agents Product Offered
11.21.3 Zydus Pharmaceuticals Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Zydus Pharmaceuticals Main Business Overview
11.21.5 Zydus Pharmaceuticals Latest Developments
11.22 Amneal Pharmaceuticals
11.22.1 Amneal Pharmaceuticals Company Information
11.22.2 Amneal Pharmaceuticals Antihypertensive Agents Product Offered
11.22.3 Amneal Pharmaceuticals Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Amneal Pharmaceuticals Main Business Overview
11.22.5 Amneal Pharmaceuticals Latest Developments
11.23 Endo International
11.23.1 Endo International Company Information
11.23.2 Endo International Antihypertensive Agents Product Offered
11.23.3 Endo International Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.23.4 Endo International Main Business Overview
11.23.5 Endo International Latest Developments
11.24 Unichem Laboratories
11.24.1 Unichem Laboratories Company Information
11.24.2 Unichem Laboratories Antihypertensive Agents Product Offered
11.24.3 Unichem Laboratories Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.24.4 Unichem Laboratories Main Business Overview
11.24.5 Unichem Laboratories Latest Developments
11.25 Huahai Pharmaceutical
11.25.1 Huahai Pharmaceutical Company Information
11.25.2 Huahai Pharmaceutical Antihypertensive Agents Product Offered
11.25.3 Huahai Pharmaceutical Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.25.4 Huahai Pharmaceutical Main Business Overview
11.25.5 Huahai Pharmaceutical Latest Developments
11.26 Shijiazhuang Pharma Group
11.26.1 Shijiazhuang Pharma Group Company Information
11.26.2 Shijiazhuang Pharma Group Antihypertensive Agents Product Offered
11.26.3 Shijiazhuang Pharma Group Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.26.4 Shijiazhuang Pharma Group Main Business Overview
11.26.5 Shijiazhuang Pharma Group Latest Developments
11.27 Shanghai Shyndec Pharmaceutical
11.27.1 Shanghai Shyndec Pharmaceutical Company Information
11.27.2 Shanghai Shyndec Pharmaceutical Antihypertensive Agents Product Offered
11.27.3 Shanghai Shyndec Pharmaceutical Antihypertensive Agents Revenue, Gross Margin and Market Share (2020-2022)
11.27.4 Shanghai Shyndec Pharmaceutical Main Business Overview
11.27.5 Shanghai Shyndec Pharmaceutical Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Antihypertensive Agents Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Thiazide Diuretics
Table 3. Major Players of Calcium Channel Blockers (CCB)
Table 4. Major Players of ACE Inhibitors
Table 5. Major Players of Angiotensin II Receptor Antagonists (ARBs)
Table 6. Antihypertensive Agents Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Antihypertensive Agents Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Antihypertensive Agents Market Size Market Share by Type (2017-2022)
Table 9. Antihypertensive Agents Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Antihypertensive Agents Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Antihypertensive Agents Market Size Market Share by Application (2017-2022)
Table 12. Global Antihypertensive Agents Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Antihypertensive Agents Revenue Market Share by Player (2020-2022)
Table 14. Antihypertensive Agents Key Players Head office and Products Offered
Table 15. Antihypertensive Agents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Antihypertensive Agents Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Antihypertensive Agents Market Size Market Share by Regions (2017-2022)
Table 20. Americas Antihypertensive Agents Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Antihypertensive Agents Market Size Market Share by Country (2017-2022)
Table 22. Americas Antihypertensive Agents Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Antihypertensive Agents Market Size Market Share by Type (2017-2022)
Table 24. Americas Antihypertensive Agents Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Antihypertensive Agents Market Size Market Share by Application (2017-2022)
Table 26. APAC Antihypertensive Agents Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Antihypertensive Agents Market Size Market Share by Region (2017-2022)
Table 28. APAC Antihypertensive Agents Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Antihypertensive Agents Market Size Market Share by Type (2017-2022)
Table 30. APAC Antihypertensive Agents Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Antihypertensive Agents Market Size Market Share by Application (2017-2022)
Table 32. Europe Antihypertensive Agents Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Antihypertensive Agents Market Size Market Share by Country (2017-2022)
Table 34. Europe Antihypertensive Agents Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Antihypertensive Agents Market Size Market Share by Type (2017-2022)
Table 36. Europe Antihypertensive Agents Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Antihypertensive Agents Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Antihypertensive Agents Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Antihypertensive Agents Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Antihypertensive Agents Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Antihypertensive Agents Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Antihypertensive Agents Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Antihypertensive Agents Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Antihypertensive Agents
Table 45. Key Market Challenges & Risks of Antihypertensive Agents
Table 46. Key Industry Trends of Antihypertensive Agents
Table 47. Global Antihypertensive Agents Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Antihypertensive Agents Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Antihypertensive Agents Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Antihypertensive Agents Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Antihypertensive Agents Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Antihypertensive Agents Market Size Market Share Forecast by Application (2023-2028)
Table 53. Baxter International Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 54. Baxter International Antihypertensive Agents Product Offered
Table 55. Baxter International Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Baxter International Main Business
Table 57. Baxter International Latest Developments
Table 58. Pfizer Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 59. Pfizer Antihypertensive Agents Product Offered
Table 60. Pfizer Main Business
Table 61. Pfizer Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Pfizer Latest Developments
Table 63. Sandoz Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 64. Sandoz Antihypertensive Agents Product Offered
Table 65. Sandoz Main Business
Table 66. Sandoz Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Sandoz Latest Developments
Table 68. Teva Pharmaceuticals Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 69. Teva Pharmaceuticals Antihypertensive Agents Product Offered
Table 70. Teva Pharmaceuticals Main Business
Table 71. Teva Pharmaceuticals Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Teva Pharmaceuticals Latest Developments
Table 73. Bayer Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 74. Bayer Antihypertensive Agents Product Offered
Table 75. Bayer Main Business
Table 76. Bayer Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Bayer Latest Developments
Table 78. Johnson & Johnson Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 79. Johnson & Johnson Antihypertensive Agents Product Offered
Table 80. Johnson & Johnson Main Business
Table 81. Johnson & Johnson Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Johnson & Johnson Latest Developments
Table 83. Sun Pharmaceutical Industries Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 84. Sun Pharmaceutical Industries Antihypertensive Agents Product Offered
Table 85. Sun Pharmaceutical Industries Main Business
Table 86. Sun Pharmaceutical Industries Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Sun Pharmaceutical Industries Latest Developments
Table 88. Merck Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 89. Merck Antihypertensive Agents Product Offered
Table 90. Merck Main Business
Table 91. Merck Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Merck Latest Developments
Table 93. AstraZeneca Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 94. AstraZeneca Antihypertensive Agents Product Offered
Table 95. AstraZeneca Main Business
Table 96. AstraZeneca Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. AstraZeneca Latest Developments
Table 98. Daiichi Sankyo Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 99. Daiichi Sankyo Antihypertensive Agents Product Offered
Table 100. Daiichi Sankyo Main Business
Table 101. Daiichi Sankyo Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Daiichi Sankyo Latest Developments
Table 103. Takeda Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 104. Takeda Antihypertensive Agents Product Offered
Table 105. Takeda Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Takeda Main Business
Table 107. Takeda Latest Developments
Table 108. Actelion Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 109. Actelion Antihypertensive Agents Product Offered
Table 110. Actelion Main Business
Table 111. Actelion Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Actelion Latest Developments
Table 113. Viatris Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 114. Viatris Antihypertensive Agents Product Offered
Table 115. Viatris Main Business
Table 116. Viatris Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Viatris Latest Developments
Table 118. United Therapeutics Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 119. United Therapeutics Antihypertensive Agents Product Offered
Table 120. United Therapeutics Main Business
Table 121. United Therapeutics Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. United Therapeutics Latest Developments
Table 123. Lupin Limited Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 124. Lupin Limited Antihypertensive Agents Product Offered
Table 125. Lupin Limited Main Business
Table 126. Lupin Limited Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Lupin Limited Latest Developments
Table 128. Hikma Pharmaceuticals Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 129. Hikma Pharmaceuticals Antihypertensive Agents Product Offered
Table 130. Hikma Pharmaceuticals Main Business
Table 131. Hikma Pharmaceuticals Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. Hikma Pharmaceuticals Latest Developments
Table 133. Aurobindo Pharma Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 134. Aurobindo Pharma Antihypertensive Agents Product Offered
Table 135. Aurobindo Pharma Main Business
Table 136. Aurobindo Pharma Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. Aurobindo Pharma Latest Developments
Table 138. Camber Pharmaceutical Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 139. Camber Pharmaceutical Antihypertensive Agents Product Offered
Table 140. Camber Pharmaceutical Main Business
Table 141. Camber Pharmaceutical Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 142. Camber Pharmaceutical Latest Developments
Table 143. Major Pharmaceuticals Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 144. Major Pharmaceuticals Antihypertensive Agents Product Offered
Table 145. Major Pharmaceuticals Main Business
Table 146. Major Pharmaceuticals Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 147. Major Pharmaceuticals Latest Developments
Table 148. Glenmark Pharmaceuticals Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 149. Glenmark Pharmaceuticals Antihypertensive Agents Product Offered
Table 150. Glenmark Pharmaceuticals Main Business
Table 151. Glenmark Pharmaceuticals Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 152. Glenmark Pharmaceuticals Latest Developments
Table 153. Zydus Pharmaceuticals Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 154. Zydus Pharmaceuticals Antihypertensive Agents Product Offered
Table 155. Zydus Pharmaceuticals Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 156. Zydus Pharmaceuticals Main Business
Table 157. Zydus Pharmaceuticals Latest Developments
Table 158. Amneal Pharmaceuticals Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 159. Amneal Pharmaceuticals Antihypertensive Agents Product Offered
Table 160. Amneal Pharmaceuticals Main Business
Table 161. Amneal Pharmaceuticals Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 162. Amneal Pharmaceuticals Latest Developments
Table 163. Endo International Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 164. Endo International Antihypertensive Agents Product Offered
Table 165. Endo International Main Business
Table 166. Endo International Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 167. Endo International Latest Developments
Table 168. Unichem Laboratories Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 169. Unichem Laboratories Antihypertensive Agents Product Offered
Table 170. Unichem Laboratories Main Business
Table 171. Unichem Laboratories Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 172. Unichem Laboratories Latest Developments
Table 173. Huahai Pharmaceutical Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 174. Huahai Pharmaceutical Antihypertensive Agents Product Offered
Table 175. Huahai Pharmaceutical Main Business
Table 176. Huahai Pharmaceutical Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 177. Huahai Pharmaceutical Latest Developments
Table 178. Shijiazhuang Pharma Group Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 179. Shijiazhuang Pharma Group Antihypertensive Agents Product Offered
Table 180. Shijiazhuang Pharma Group Main Business
Table 181. Shijiazhuang Pharma Group Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 182. Shijiazhuang Pharma Group Latest Developments
Table 183. Shanghai Shyndec Pharmaceutical Details, Company Type, Antihypertensive Agents Area Served and Its Competitors
Table 184. Shanghai Shyndec Pharmaceutical Antihypertensive Agents Product Offered
Table 185. Shanghai Shyndec Pharmaceutical Main Business
Table 186. Shanghai Shyndec Pharmaceutical Antihypertensive Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 187. Shanghai Shyndec Pharmaceutical Latest Developments
List of Figures
List of Figures
Figure 1. Antihypertensive Agents Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antihypertensive Agents Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Antihypertensive Agents Market Size Market Share by Type in 2021
Figure 7. Antihypertensive Agents in Children
Figure 8. Global Antihypertensive Agents Market: Children (2017-2022) & ($ Millions)
Figure 9. Antihypertensive Agents in Adult
Figure 10. Global Antihypertensive Agents Market: Adult (2017-2022) & ($ Millions)
Figure 11. Global Antihypertensive Agents Market Size Market Share by Application in 2021
Figure 12. Global Antihypertensive Agents Revenue Market Share by Player in 2021
Figure 13. Global Antihypertensive Agents Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Antihypertensive Agents Market Size 2017-2022 ($ Millions)
Figure 15. APAC Antihypertensive Agents Market Size 2017-2022 ($ Millions)
Figure 16. Europe Antihypertensive Agents Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Antihypertensive Agents Market Size 2017-2022 ($ Millions)
Figure 18. Americas Antihypertensive Agents Value Market Share by Country in 2021
Figure 19. Americas Antihypertensive Agents Consumption Market Share by Type in 2021
Figure 20. Americas Antihypertensive Agents Market Size Market Share by Application in 2021
Figure 21. United States Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Antihypertensive Agents Market Size Market Share by Region in 2021
Figure 26. APAC Antihypertensive Agents Market Size Market Share by Application in 2021
Figure 27. China Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Antihypertensive Agents Market Size Market Share by Country in 2021
Figure 34. Europe Antihypertensive Agents Market Size Market Share by Type in 2021
Figure 35. Europe Antihypertensive Agents Market Size Market Share by Application in 2021
Figure 36. Germany Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Antihypertensive Agents Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Antihypertensive Agents Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Antihypertensive Agents Market Size Market Share by Application in 2021
Figure 44. Egypt Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Antihypertensive Agents Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 50. APAC Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 51. Europe Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 53. United States Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 54. Canada Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 57. China Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 58. Japan Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 59. Korea Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 61. India Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 62. Australia Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 63. Germany Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 64. France Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 65. UK Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 66. Italy Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 67. Russia Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 68. Spain Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 71. Israel Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Antihypertensive Agents Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets